argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings
Argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings - read this article along with other careers information, tips and advice on BioSpace
United States Chafic Karam Michelle Greenblatt Gregoryw Fulton Demyelinating Polyneuropathy Jeffrey Guptill
Source: biospace.com